1. Vital Statistics Division, Statistics Korea; Noh H, et al.; Seo J. Cause-of-death statistics in 2020 in the Republic of Korea. J Korean Med Assoc 2023;66:132–142.
6. Martiniuk AL, Lee CM, Lawes CM, et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007;25:73–79.
9. Garovic VD, Dechend R, Easterling T, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension 2022;79:e21–e41.
10. Cho L, Davis M, Elgendy I, et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2602–2618.
11. Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 2021;397:2385–2438.
16. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999;99:1165–1172.
19. Hansel B, Kontush A, Giral P, Bonnefont-Rousselot D, Chapman MJ, Bruckert E. One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié Study. Curr Med Res Opin 2006;22:1149–60.
20. Song K, Jeon S, Lee HS, et al. Trends of dyslipidemia in Korean youth according to sex and body mass index: based on the Korea National Health and Nutrition Examination Survey (2007–2018). J Pediatr 2021;237:71–78e5.
22. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii1–253.
24. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–163.
32. Bellettiere J, LaMonte MJ, Evenson KR, et al. Sedentary behavior and cardiovascular disease in older women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study. Circulation 2019;139:1036–1046.
33. Arafa A, Lee HH, Eshak ES, et al. Modifiable risk factors for cardiovascular disease in Korea and Japan. Korean Circ J 2021;51:643–655.
41. Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation 2018;137:e843–e852.
45. Adedinsewo DA, Pollak AW, Phillips SD, et al. Cardiovascular disease screening in women: leveraging artificial intelligence and digital tools. Circ Res 2022;130:673–690.
46. Kim HJ, Kim HY, Kim HL, et al. Awareness of cardiovascular disease among Korean women: results from a nationwide survey. Prev Med Rep 2022;26:101698.
47. Carnethon MR, Hill JA, Al-Khatib SM. Eighth annual go red for women issue. Circulation 2024;149:487–488.